Parmax Pharma has informed that it enclosed summary of the proceedings as required under Regulation 30, Part-A of Schedule-III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations with respect to 27th Annual General Meeting (AGM) of the company held on Monday, 20th September, 2021 at 2:00 pm till 3.00 pm at the registered office of the company.
The above information is a part of company’s filings submitted to BSE.